NEXT Oncology Dallas — Irving, Texas

NEXT Oncology Dallas is a clinical research site located in Irving, Texas, United States 75039.

Crixeo Clinical Trials Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

NEXT Oncology Dallas has participated in 8 clinical trials with 8 currently active.

Therapeutic areas: Advanced Solid Tumor, NSCLC (Non-small Cell Lung Cancer), Renal Cancer.

Sponsors: Nuvectis Pharma, Inc., Revolution Medicines, Inc., Georgiamune Inc.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NEXT Oncology Dallas?

NEXT Oncology Dallas has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NEXT Oncology Dallas conducted?

NEXT Oncology Dallas has 8 clinical trials on record, with 8 currently active. Their work covers Advanced Solid Tumor, NSCLC (Non-small Cell Lung Cancer), Renal Cancer.

Is NEXT Oncology Dallas accredited by Crixeo Clinical Trials?

NEXT Oncology Dallas has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NEXT Oncology Dallas?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.